|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7004 | |
| A61K 31/351 | |||
| A61P 19/06 |
| (11) | Number of the document | 2291189 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09751249.5 |
| Date of filing the European patent application | 2009-05-15 | |
| (97) | Date of publication of the European application | 2011-03-09 |
| (45) | Date of publication and mention of the grant of the patent | 2014-10-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/044156 |
| Date | 2009-05-15 |
| (87) | Number | WO 2009/143020 |
| Date | 2009-11-26 |
| (30) | Number | Date | Country code |
| 55352 P | 2008-05-22 | US |
| (72) |
LESLIE, Bruce, Robert, US
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | METHOD FOR TREATING HYPERURICEMIA EMPLOYING AN SGLT2 INHIBITOR AND COMPOSITION CONTAINING SAME |
| METHOD FOR TREATING HYPERURICEMIA EMPLOYING AN SGLT2 INHIBITOR AND COMPOSITION CONTAINING SAME |